UnknownNot Applicable

The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules

China200 participantsStarted 2018-05-03

Plain-language summary

* The purpose of the study is the identification of the efficacy of MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules. * In this study, the investigators are going to validate the efficacy of the MDA test for diagnosing early lung cancer by comparing results of the pre-surgery MDA test with the post-surgery pathology.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years old or above * single pulmonary nodule found by CT scan. * the diameter of the pulmonary nodule is between 5mm to 30mm. * plan to accept pneumonectomy due to the pulmonary nodule. * agree to sign informed consent Exclusion Criteria: * fail to understand or agree to sign informed consent. * pregnant or lactating women. * the diameter of the pulmonary nodule is more than 30mm. * there are 2 or more pulmonary nodules in one single patient.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Early detection of lung cancer

Timeframe: 6 months

Trial details

NCT IDNCT03790735

SponsorTianjin Medical University Cancer Institute and Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-03

Contact for this trial

Dongyan Cheng

(022)23340123-6012 chengdongyan916@163.com

View on ClinicalTrials.gov More Pulmonary Nodule, Solitary trials